Avedro
Avedro, founded in 2009, is a privately held commercial-stage ophthalmic medical technology company focused on treating corneal ectatic disorders and improving vision to reduce dependency on eyeglasses or contact lenses.
Latest 蘑菇视频APP from Avedro
- Avedro Receives FDA Approval for Photrexa庐 Viscous, Photrexa庐 and the KXL庐 System for Corneal Cross-Linking 04.18.2016
- China Food and Drug Administration (CFDA) Grants Approval for Avedro鈥檚 KXL庐 System 11.03.2015
- Avedro Receives the European Union鈥檚 CE Mark for its Vedera鈩� Ophthalmic Device 04.20.2010